Samuel Bates Martin - 02 Jan 2024 Form 4 Insider Report for Celldex Therapeutics, Inc. (CLDX)

Role
SVP AND CFO
Signature
/s/ Anthony S. Marucci, attorney-in-fact for Samuel Bates Martin
Issuer symbol
CLDX
Transactions as of
02 Jan 2024
Net transactions value
+$29,885
Form type
4
Filing time
04 Jan 2024, 16:05:44 UTC
Previous filing
20 Jun 2023
Next filing
03 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLDX Common Stock Options Exercise $29,885 +10,750 +44% $2.78* 35,128 02 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLDX Incentive Stock Option (Right to Buy) Options Exercise $0 -10,750 -100% $0.000000* 0 02 Jan 2024 Common Stock 10,750 $2.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As of June 19, 2023, the option is fully vested.